Megan Rothney is VP of Product at PathAI. Megan is responsible for PathAI’s platform development, productionized ML algorithms, and product design. Prior to PathAI Megan led the Baseline Health Study at Verily Life Sciences where she developed platform features and data products for large scale, multimodal, and decentralized clinical trials. Megan has been working in the healthcare space for more than 10 years and has led product and strategy initiatives at Exact Sciences and GE including driving double digit year over year revenue growth in the Oncotype Dx oncology products, building the medical affairs launch strategy for Cologuard, and building data visualizations for the MultiOmyx pathology platform. Megan holds a BSE from the University of Pittsburgh, MS and PhD in biomedical engineering from Vanderbilt University and completed pre- and postdoctoral fellowships at the NIH.